Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Phyllodes tumor of the prostate.

Fujii T, Shimada K, Tanaka N, Fujimoto K, Konishi N.

Pathol Int. 2012 Mar;62(3):204-8. doi: 10.1111/j.1440-1827.2012.02796.x.

PMID:
22360509
2.

[Giant phyllodes tumor of the prostate].

Kawamorita N, Inaba Y, Soma F, Katayama Y, Mikami Y.

Nihon Hinyokika Gakkai Zasshi. 2007 Sep;98(6):781-5. Japanese.

3.

Phyllodes tumor of the prostate: long-term followup study of 23 cases.

Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, di Sant'agnese PA, Jones EC.

J Urol. 2004 Sep;172(3):894-9.

PMID:
15310992
4.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
5.

Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.

Wang X, Jones TD, Zhang S, Eble JN, Bostwick DG, Qian J, Lopez-Beltran A, Montironi R, Harris JJ, Cheng L.

Mod Pathol. 2007 Feb;20(2):175-82. Epub 2006 Dec 22.

6.

Phyllodes tumor of the prostate: a case report.

Ito H, Ito M, Mitsuhata N, Tahara E.

Jpn J Clin Oncol. 1989 Sep;19(3):299-304. Review.

PMID:
2478740
7.

Lung metastases of low grade phyllodes tumor of the prostate: histopathologic confirmation.

Parada D, Ugas G, Peña K, Caricote L, Mujica N.

Arch Esp Urol. 2008 Jun;61(5):658-62. Review.

PMID:
18709826
8.

Phyllodes tumor of the seminal vesicle: case report and literature review.

Son HJ, Jeong YJ, Kim JH, Chung MJ.

Pathol Int. 2004 Dec;54(12):924-9.

PMID:
15598315
9.

[Prostatic phyllodes tumor, a rare entity. Anatamo-clinical and immunohistochemical study of 1 case].

Chatelain D, Coppola S, De Pinieux G, David E, Viellefond A.

Ann Pathol. 2000 Dec;20(6):629-32. French.

PMID:
11148362
10.

Cystosarcoma phyllodes of the prostate.

Cacić M, Petrović D, Tentor D, Hutinec Z, Jelasić D.

Scand J Urol Nephrol. 1996 Dec;30(6):501-2.

PMID:
9008035
11.

Giant cystosarcoma phyllodes tumor of prostate: case report of a rare entity.

Bhat DM, Poflee SV, Kotwal MN, Pangarkar MA, Gadkari RU, Bobhate SK.

Indian J Cancer. 2004 Jul-Sep;41(3):129-32.

12.

Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.

Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9.

PMID:
15050332
13.

Malignant phyllodes tumor of the prostate.

Kim HS, Lee JH, Nam JH, Lee MC, Park CS, Juhng SW, Ro JY, Choi C.

Pathol Int. 1999 Dec;49(12):1105-8.

PMID:
10632933
14.

Phyllodes tumor of the prostate with exuberant glandular hyperplasia.

Morikawa T, Nagata M, Tomita K, Kitamura T, Goto A, Chong JM, Fukayama M.

Pathol Int. 2006 Mar;56(3):158-61.

PMID:
16497250
15.

Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?

de la Taille A, Rubin MA, Bagiella E, Olsson CA, Buttyan R, Burchardt T, Knight C, O'Toole KM, Katz AE.

J Urol. 1999 Jul;162(1):103-6.

PMID:
10379750
16.

Phyllodes tumor of the prostate: recurrent obstructive symptom and stromal proliferative activity.

Shiraishi K, Mohri J, Eguchi S, Kamiryo Y, Sanefuji H.

Int J Urol. 2004 Sep;11(9):801-4.

17.
18.
19.

Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less.

D'Amico AV, Chen MH, Malkowicz SB, Whittington R, Renshaw AA, Tomaszewski JE, Samofalov Y, Wein A, Richie JP.

J Urol. 2002 May;167(5):2025-30; discussion 2030-1.

PMID:
11956431
20.

Medically and economically appropriate follow-up schedule for prostate cancer patients after radical prostatectomy.

Niwakawa M, Tobisu K, Fujimoto H, Matsuoka N, Kakizoe T.

Int J Urol. 2002 Mar;9(3):134-40.

Supplemental Content

Support Center